Food Standards (Application A1210 – Maltogenic alpha-amylase enzyme from GM Saccharomyces cerevisiae) Variation (Cth)

Case
No judgment structure available for this case.

Food Standards (Application A1210 – Maltogenic alpha-amylase enzyme from GM Saccharomyces cerevisiae) Variation

The Board of Food Standards Australia New Zealand gives notice of the making of this variation under section 92 of the Food Standards Australia New Zealand Act 1991.  The variation commences on the date specified in clause 3 of this variation.

Dated 20 August 2021

Sally Ronaldson

Delegate of the Board of Food Standards Australia New Zealand

Note: 

This variation will be published in the Commonwealth of Australia Gazette No. FSC 143 on 26 August 2021. This means that this date is the gazettal date for the purposes of clause 3 of the variation.

1             Name

This instrument is the Food Standards (Application A1210 – Maltogenic alpha-amylase enzyme from GM Saccharomyces cerevisiae) Variation.

2             Variation to a Standard in the Australia New Zealand Food Standards Code

The Schedule varies a Standard in the Australia New Zealand Food Standards Code.

3             Commencement

The variation commences on the date of gazettal.

Schedule

[1]           Schedule 18 is varied by

[1.1]        inserting into the table to subsection S18—9(3), in alphabetical order

Maltogenic α-amylase, protein engineered variant, (EC 3.2.1.133) sourced from Saccharomyces cerevisiae containing the gene for maltogenic α-amylase from Geobacillus stearothermophilus.

For use in the manufacture of bakery products

GMP

[1.2]        inserting after the table to subsection S18—9(3)

Note    Some enzyme sources identified in this table are protein engineered. If such an enzyme is used as a processing aid, the resulting food may have as an ingredient a food produced using gene technology, and the requirements relating to foods produced using gene technology will apply—see Standard 1.2.1 and Standard 1.5.2. The relevant enzymes are the following:

●          Endo-1,4-ß-xylanase, protein engineered variant;

●          Maltogenic α-amylase, protein engineered variant;

●          Protein engineered enzymes used in the manufacture of various steviol glycosides.

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0